H-1B filings

Does Bayer HealthCare Pharmaceuticals Inc. sponsor H-1B?

Yes, according to public filings. Bayer HealthCare Pharmaceuticals Inc. filed 21 H-1B labor condition applications in fiscal years 2025-2026, including 10 in fiscal year 2026.

USCIS approved 15 H-1B petitions for this employer in fiscal years 2025-2026.

This page uses public government filings. A filing does not guarantee that the employer will sponsor you. This information is not legal advice.

Status on October 22, 2026: USCIS does not collect the $100,000 payment on new H-1B petitions for workers outside the U.S. while court orders stand. Appeals are pending, so this can change. USCIS H-1B FAQ

Labor condition applications by fiscal year

Fiscal yearFiledCertifiedWorkers
2026101010
2025111010

An employer files a labor condition application with the Department of Labor before it files an H-1B petition. A certified application is not an approved visa. The U.S. fiscal year runs from October 1 to September 30.

USCIS decisions on H-1B petitions by fiscal year

Fiscal yearNew: approvedNew: deniedContinuing: approvedContinuing: denied
20261060
20251070

New petitions are for first H-1B employment. Continuing petitions are for extensions and for workers who change employers.

Typical roles and wage ranges

Job titleApplicationsWage range per yearMedian
Scientist (In Vitro Specialist, Cvri)2$110,000 - $110,000$110,000
Scientist2$95,000 - $110,000$110,000
Medical Affairs Data Analyst2$160,000 - $160,000$160,000
Lead Medical Science Liaison2$224,000 - $224,000$224,000
Senior Scientist2$133,705 - $133,705$133,705
Sr. Clinical Quantitative Scientist1$170,000 - $170,000$170,000
Associate Director Lead Statistician1$176,000 - $176,000$176,000
Sr. Manager Principal Clinical Data Management1$169,541 - $169,541$169,541
Assoc Dir Seg Targeting Sizing1$243,283 - $243,283$243,283
Director, Field Health Economics & Outcomes Resear1$245,000 - $245,000$245,000

Wages are the rates the employer stated in its applications. Actual pay can differ.

Top locations

Sources

Data release 2026q3, built on October 23, 2026.